Sherpa Blog EU GDP Guidelines: Implications for Shipping Clinical Materials into the European Market

March 27, 2018Change Your PerspectiveEU Good Distribution Practices (GDP) require that sponsor companies have a thorough understanding of how clinical supplies are handled and temperature monitored.For example, do your clinical sites know what to do with the physical temperature monitors upon receipt? It is not uncommon for clinical sites to receive temperature-controlled supplies and mishandle the physical temperature monitors. This can lead to the loss of data and may prevent use of your trial product. This paper explains the EU GDP Guidelines and implications for shipping clinical materials into and throughout the European market.